BioXcel Therapeutics
BTAI
#10059
Rank
A$16 M
Marketcap
$2.93
Share price
1.08%
Change (1 day)
-95.62%
Change (1 year)

BioXcel Therapeutics (BTAI) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : A$0.20 Billion

According to BioXcel Therapeutics's latest financial reports the company's total liabilities are A$0.20 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BioXcel Therapeutics - Total liabilities on balance sheet (from 2017 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$0.19 B0.76%
2022-12-31A$0.18 B673.77%
2021-12-31A$24.51 M42.37%
2020-12-31A$17.21 M26.94%
2019-12-31A$13.56 M105.06%
2018-12-31A$6.61 M120.98%
2017-12-31A$2.99 M551.89%
2016-12-31A$0.45 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$48.54 M-76.40%๐Ÿ‡บ๐Ÿ‡ธ USA